A case of small cell carcinoma of the prostate and review of the literature

Tumori

Volumn 98, Issue 3, 2012, Pages

  Addeo, Alfredo ^a   Rinaldi, Ciro ^a   Panades, Miguel ^a  

^a UNITED LINCOLNSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Neuroendocrine tumors; Prostate cancer; Prostate specific antigen; Small cell cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBOPLATIN; CD56 ANTIGEN; CHROMOGRANIN; CYTOKERATIN AE1; CYTOKERATIN AE3; ETOPOSIDE; KI 67 ANTIGEN; LEUPRORELIN; NEURON SPECIFIC ENOLASE; PROSTATE SPECIFIC ANTIGEN; THYROID TRANSCRIPTION FACTOR 1;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACKACHE; BILIRUBIN BLOOD LEVEL; BONE METASTASIS; BONE SCINTISCANNING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CAUSE OF DEATH; DIFFERENTIAL DIAGNOSIS; DIGITAL RECTAL EXAMINATION; DRUG DOSE REDUCTION; DRUG RESPONSE; GLEASON SCORE; HIP PAIN; HUMAN; HUMAN TISSUE; LIMB WEAKNESS; LIVER BIOPSY; LIVER METASTASIS; LUNG EMBOLISM; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; RECTUM BIOPSY; SMALL CELL CARCINOMA; SMALL CELL CARCINOMA OF THE PROSTATE; SPINAL CORD COMPRESSION;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SMALL CELL; ETOPOSIDE; FATAL OUTCOME; HUMANS; LEUPROLIDE; LIVER NEOPLASMS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PULMONARY EMBOLISM; TUMOR MARKERS, BIOLOGICAL;

EID: 84867089337     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800323     Document Type: Article

References (20)

1. Yashi M, Terauchi F, Nukui A, Ochi M, Yuzawa M, Hara Y, Morita T: Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review. Urol Oncol, 24: 313-317, 2006. (Pubitemid 43963405)
2. Jelbart ME, Russell PJ, Russell P, Raghavan D: The biology and management of small cell undifferentiated carcinoma of the prostate. In: Textbook of uncommon cancer, Williams CJ, Krikorian JG, Green MR, Raghaven D (Eds), pp 249-262, Wiley, London, 1988.
3. Wenk RE, Bhagavan BS, Levy R, Miller D, Weisburger W: Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer, 40: 773-778, 1977. (Pubitemid 8177897)
4. Oesterling JE, Hauzeur CG, Farrow GM: Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol, 147: 804-807, 1992.
5. Horwich A, Waxman J, Schroder FH: Tumours of the prostate. In: Oxford textbook of oncology, vol 2, Peckham M, Pinedo B, Veronesi U (Eds), pp 1498-1530, Oxford University Press, Oxford, 1995.
6. Palmgren JS, Karavadia SS, Wakefield MR: Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol, 34: 22-29, 2007. (Pubitemid 46161758)
7. Petraki C, Vaslamatzis M, Petraki K, Revelos K, Alevizopoulos N, Papanastasiou P, Gregorakis A: Prostate cancer with small-cell morphology: an immunophenotypic subdivision. Scand J Urol Nephrol, 39: 455-463, 2005. (Pubitemid 41722025)
8. Ro JY, Têtu B, Ayala AG, Ordóñez NG: Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases. Cancer, 59: 977-982, 1987. (Pubitemid 17024655)
9. Di Sant'Agnese P: Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer, 70: 254-268, 1992.
10. Abrahamsson PA, Waldström LB, Aluments J, Falkmer S, Grimelius L: Peptide-hormone- and serotonin-immunoreactive tumor cells in carcinoma of the prostate. Pathol Res Pract, 182: 298-307, 1987.
11. Aprikian AG, Cordon-Cardo L, Fair WR, Reuter VE: Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer, 71: 3952-3956, 1993.
12. Aygun C: Small cell carcinoma of the prostate: a case report and review of the literature. Md Med J, 46: 353-356, 1997.
13. Helpap B, Köllermann J, Oehler U: Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int, 62: 133-138, 1999. (Pubitemid 29473966)
14. Aprikian AG, Cordon-Cardo L, Fair WR, Zhang ZF, Bazinet M, Hamdy SM, Reuter VE: Neuroendocrine differentiation in metastatic prostatic carcinoma. J Urol, 251: 914-919, 1994. (Pubitemid 24083459)
15. Carney D, Marangos PJ, Ihde DC, Bunn PA Jr, Cohen MH, Minna JD, Gazdar AF: Serum neuron-enolase. A marker for disease extent and response to therapy of small cell lung cancer. Lancet, 319: 583-585, 1982. (Pubitemid 12171820)
16. Johnson DH, Marangos PJ, Forbes TJ, Hainsworth JD, Van Welch R, Hande KR, Greco FA: Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung. Cancer Res, 35: 234-238, 1984.
17. Rubenstein JH, Katin MJ, Mangano MM, Dauphin J, Salenius SA, Dorotezt DE, Blitzer PH: Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol, 20: 376-380, 1997. (Pubitemid 27329571)
18. Aoki H, Ishidoya S, Ito A, Endoh M, Shimazui T, Arai Y: Experience of the treatment with gemcitabine, docetacxel and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate. Int J Urol, 13: 1254-1258, 2006. (Pubitemid 44410923)
19. Asmis TR, Reaume MN, Dahrouge S, Malone S: Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at the Ottawa Hospital Regional Cancer Center. BJU Int, 97: 711-715, 2006. (Pubitemid 43383500)
20. Rossi A, Maione P, Palazzolo G, Sacco PC, Ferrara ML, Falanga M, Gridelli C: New targeted therapies and small-cell lung cancer. Clin Lung Cancer, 9: 271-279, 2008.